Express Scripts Says Claims In $15B Pricing Dispute Hold Up
Express Scripts Inc. urged a New York federal court Friday to uphold its counterclaims against Anthem Inc. in a $15 billion breach-of-contract suit, arguing that its agreement to administer prescription drug...To view the full article, register now.
Already a subscriber? Click here to view full article